Method for detecting content of compound paracetamol and amantadine hydrochloride capsules
The potentiometric titration method solves the problems of reliance on personnel experience and environmental pollution in the detection of compound acetaminophen and amantadine capsules, achieving rapid and accurate content detection and improving the reproducibility of the detection.
Patent Information
- Application Number
- CN202610101996.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-01-26
- Publication Date
- 2026-04-24
AI Technical Summary
The existing quality standards for compound acetaminophen and amantadine capsules are not perfect. Manual titration relies on personnel experience and has poor reproducibility, while high performance liquid chromatography is time-consuming and causes environmental pollution.
Potentiometric titration was used to titrate amantadine hydrochloride and acetaminophen in compound acetaminophen and amantadine capsules using silver and double platinum electrodes, respectively. The endpoint was determined by the potentiometric titrator, which reduced human error and improved the reproducibility of the test.
It enables endpoint determination to be independent of human experience, and the detection process is fast and pollution-free, improving the reproducibility and accuracy of compound acetaminophen and amantadine capsule content detection.
Smart Images

Figure SMS_1 
Figure SMS_2 
Figure SMS_3
Abstract
Description
Technical Field
[0001] This invention relates to the field of pharmaceutical analysis, and in particular to a method for detecting the content of compound acetaminophen and amantadine capsules. Background Technology
[0002] The current quality standards for Compound Paracetamol and Amantadine Capsules have some shortcomings. The quality standards for Compound Paracetamol and Amantadine Capsules in Volume 5 of the Drug Standards (Part II) of the Ministry of Health of the People's Republic of China all use manual titration method to determine the content. The determination of the titration endpoint requires a high level of experience from the personnel and has poor reproducibility.
[0003] CN108254464A provides a method for "detecting the content of amantadine hydrochloride in compound acetaminophen and amantadine capsules by HPLC-ELSD, and detecting the content of acetaminophen, caffeine and chlorpheniramine maleate in compound acetaminophen and amantadine capsules by HPLC". The detection of amantadine hydrochloride and acetaminophen relies on high performance liquid chromatography, but this method has drawbacks such as long time consumption, cumbersome sample processing, and environmental pollution caused by the mobile phase in the testing process. Summary of the Invention
[0004] In view of this, the present invention proposes a method for detecting the content of compound acetaminophen and amantadine capsules, which achieves endpoint determination without relying on human experience, has good reproducibility, is faster, and has a pollution-free testing process.
[0005] The technical solution of this invention is implemented as follows: A method for detecting the content of compound acetaminophen and amantadine capsules includes the following steps: (1) Take the contents of compound acetaminophen and amantadine capsules, grind them into a fine powder, weigh them accurately, place them in a container, add water to dissolve and dilute to a fixed volume, shake well, filter, accurately measure the filtrate, use potentiometric titration, titrate with silver nitrate titrant to the endpoint, and calculate the content of amantadine hydrochloride in compound acetaminophen and amantadine capsules. (2) Take the contents of the compound acetaminophen and amantadine capsules, grind them into a fine powder, weigh them accurately, place them in a container, add hydrochloric acid and first water, heat to reflux, cool to room temperature, add second water, insert the tip of the burette below the liquid surface, use potentiometric titration, and quickly titrate to the endpoint with sodium nitrite titrant, and calculate the content of acetaminophen in the compound acetaminophen and amantadine capsules.
[0006] Furthermore, the electrode used in step (1) is a silver electrode.
[0007] Further, in step (1), the concentration of the compound acetaminophen and amantadine capsules is 15-20 mg / ml, preferably 16.4 mg / ml.
[0008] Further, in step (1), the concentration of the silver nitrate titrant is 0.08-0.012 mol / L, preferably 0.1 mol / L.
[0009] Furthermore, the electrode used in step (2) is a double platinum electrode.
[0010] Further, in step (2), the mass-to-volume ratio of compound acetaminophen capsules to hydrochloric acid, first water, and second water is 0.49g:(45-55)ml:(45-55)ml:(45-55)ml.
[0011] Furthermore, in step (2), the concentration of the hydrochloric acid is 1-6 mol / L.
[0012] Further, in step (2), the concentration of the sodium nitrite titrant is 1-6 mol / L.
[0013] Furthermore, in step (2), the heating and reflux time is 0.8-1.2h.
[0014] Further, in steps (1) and (2), the potentiometric titration parameters are as follows: the electrode type is mV, the electrode model is DM141-SC; the stirring speed is 30% of the maximum speed of the stirrer; the titrant addition mode is dynamic addition mode, the minimum titration volume is 0.008mL, the maximum titration volume is 0.4mL, and the potential increment setting value is 9.0mV; the balance control mode is set, the potential change threshold is 0.5mV, the potential detection interval is 1s, the minimum waiting time is 3s, and the maximum waiting time is 30s; the endpoint determination adopts the standard evaluation mode, and the first derivative threshold is set to 50mV / mL.
[0015] Compared with the prior art, the beneficial effects of the present invention are: The detection method of the present invention uses potentiometric titration to achieve endpoint determination without relying on human experience, with good reproducibility, faster speed, and no pollution in the testing process, thus enabling the detection of the content of compound acetaminophen and amantadine capsules. Detailed Implementation
[0016] To better understand the technical content of this invention, specific embodiments are provided below to further illustrate the invention.
[0017] Unless otherwise specified, the experimental methods used in the embodiments of this invention are all conventional methods.
[0018] Unless otherwise specified, all materials and reagents used in the embodiments of this invention are commercially available.
[0019] The compound acetaminophen and amantadine capsules used in this invention are manufactured by Hainan Asia Pharmaceutical Co., Ltd., with batch number 01250301.
[0020] Example 1 A method for detecting the content of compound acetaminophen and amantadine capsules includes the following steps: Step (1): Take the contents of 20 capsules of Compound Paracetamol and Amantadine Capsules, grind them into a fine powder, accurately weigh two portions (about 1.64g, which is equivalent to 0.4g of Amantadine Hydrochloride), place them in a 100ml volumetric flask, add water to dissolve and dilute to the mark, shake well, filter with dry quantitative filter paper, accurately measure 50ml of the filtrate, use potentiometric titration, select a silver electrode, titrate with silver nitrate titrant (0.1mol / L) to the endpoint, and calculate the content of Amantadine Hydrochloride in Compound Paracetamol and Amantadine Capsules; The potentiometric titrator used in step (1) is a T5 automatic potentiometric titrator manufactured by Mettler Toledo Instruments (Shanghai) Co., Ltd., and the potentiometric titration parameters are shown in Table 1.
[0021] Table 1. Potentiometric titration parameters for the detection of amantadine hydrochloride content in compound acetaminophen and amantadine capsules.
[0022] Step (2): Take the contents of 20 capsules of this product, grind them into a fine powder, accurately weigh two portions (about 0.49g, which is equivalent to 0.3g of acetaminophen), place them in 250ml conical flasks, add 50ml of 1mol / L dilute hydrochloric acid and 50ml of water, heat under reflux for 1 hour, cool to room temperature, add 50ml of water, insert the tip of the burette into the liquid about 2 / 3 below the surface, use potentiometric titration, select a double platinum electrode, and quickly titrate to the endpoint with sodium nitrite titrant (0.1mol / L), and calculate the content of acetaminophen in the compound acetaminophen and amantadine capsules.
[0023] The potentiometric titrator used in step (2) is a T5 automatic potentiometric titrator manufactured by Mettler Toledo Instruments (Shanghai) Co., Ltd., and the potentiometric titration parameters are shown in Table 2.
[0024] Table 2. Potentiometric titration parameters for the detection of acetaminophen content in compound acetaminophen and amantadine capsules.
[0025] Comparative Example 1 The amantadine hydrochloride content of Compound Paracetamol and Amantadine Capsules was tested according to the standard method (manual titration), and the standard implemented was the quality standard of "Compound Paracetamol and Amantadine Capsules" in Volume 5 of the Drug Standards (Part II) of the Ministry of Health of the People's Republic of China.
[0026] 1. Titration process Take the contents from the volume variation section, grind them finely, accurately weigh two portions of the compound acetaminophen and amantadine capsules (approximately 1.64g, which is approximately equivalent to 0.4g of amantadine hydrochloride), place them in a 100ml volumetric flask, add water to dissolve and dilute to the mark, shake well, filter through dry quantitative filter paper, accurately measure 50ml of the filtrate, add 2 drops of bromophenol blue indicator, add 36% acetic acid solution dropwise to change the solution from blue-purple to yellow-green, add 6 drops of bromophenol blue indicator, and titrate with silver nitrate titrant (0.1mol / L) until the precipitate turns gray-purple, which is the endpoint.
[0027] 2 Calculation
[0028] In the formula, V represents the volume of titrant consumed by the sample, in ml; F is the concentration conversion value of the titrant, where F = measured concentration of the titrant / specified concentration of the titrant; W - Mass of the test sample, in grams; T-titer, [each 1 ml of titrant (0.1 mol / L) is equivalent to 18.77 mg of the analyte].
[0029] Comparative Example 2 The acetaminophen content of Compound Paracetamol and Amantadine Capsules was tested according to the standard method (manual titration), and the standard implemented was the quality standard of "Compound Paracetamol and Amantadine Capsules" in Volume 5 of the Drug Standards (Part II) of the Ministry of Health of the People's Republic of China.
[0030] 1. Blank titration Measure 50 ml of dilute hydrochloric acid and 50 ml of water into a 250 ml Erlenmeyer flask, heat under reflux for 1 hour, cool to room temperature, add 50 ml of water and 3 g of potassium bromide, insert the tip of the burette about 2 / 3 below the liquid surface, and titrate rapidly with sodium nitrite titrant (0.1 mol / L), stirring constantly. When near the endpoint, remove the tip of the burette from the liquid surface, wash the tip with a small amount of water, and add the washings to the solution. Continue titrating slowly until a blue streak appears when a small amount of solution is dipped into a fine glass rod and swirls it across a white porcelain plate coated with zinc iodide starch indicator solution. Stop titrating when, after five minutes, the same small amount of solution is dipped into the burette and swirls it again. If a blue streak still appears, this is the endpoint, recorded as Vo.
[0031] 2. Titration of the test sample Take the finely ground powder above, accurately weigh two portions of compound acetaminophen and amantadine capsules (approximately 0.49g, equivalent to about 0.3g of acetaminophen), and place them separately in 250ml conical flasks. Add 50ml of dilute hydrochloric acid and 50ml of water, heat under reflux for 1 hour, cool to room temperature, add 50ml of water and 3g of potassium bromide, insert the tip of the burette about 2 / 3 below the liquid surface, and titrate rapidly with sodium nitrite titrant (0.1mol / L), stirring constantly. When near the endpoint, remove the tip of the burette from the liquid surface, wash the tip with a small amount of water, and add the washings to the solution. Continue titrating slowly until a small amount of solution is dipped into a fine glass rod and swirls across a white porcelain plate coated with zinc iodide starch indicator solution, and a blue streak appears. Stop titrating when a blue streak appears. After five minutes, dip a small amount of solution again and swirl across the plate once more. If a blue streak still appears, this is the endpoint, recorded as V.
[0032] 3 Calculation
[0033] In the formula, Vo represents the volume of the blank titrant consumed, in ml; V represents the volume of titrant consumed by the sample, in ml; F is the concentration conversion value of the titrant, where F = measured concentration of the titrant / specified concentration of the titrant; W - Mass of the test sample, in grams; T-titer, [each 1 ml of titrant (0.1 mol / L) is equivalent to 15.12 mg of the analyte].
[0034] The results of Comparative Examples 1-2 in Tables 3 and 4 were obtained by experienced experimenters. Color determination involves subjective human intervention. The determination of the grayish-purple color in Comparative Example 1 and the determination of the blue streak in Comparative Example 2 were made jointly by Personnel 1 and Personnel 2, respectively.
[0035] Table 3 compares the detection results of amantadine hydrochloride content in compound acetaminophen and amantadine capsules.
[0036] Table 4 Comparison of acetaminophen content detection results in compound acetaminophen and amantadine capsules
[0037] As can be seen from the above data, the detection method of the present invention not only ensures the accuracy of the results of the original manual titration method, but also achieves the benefits of endpoint determination not relying on human experience and good reproducibility.
[0038] In summary, the detection method of the present invention utilizes potentiometric titration to achieve endpoint determination without relying on human experience, with good reproducibility, faster speed, and no pollution during the testing process, thus enabling the detection of the content of compound acetaminophen and amantadine capsules.
[0039] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modifications, equivalent substitutions, improvements, etc., made within the scope of the present invention should be included within the protection scope of the present invention.
Claims
1. A method for detecting the content of compound acetaminophen and amantadine capsules, characterized in that, Includes the following steps: (1) Take the contents of compound acetaminophen and amantadine capsules, grind them into a fine powder, weigh them accurately, place them in a container, add water to dissolve and dilute to a fixed volume, shake well, filter, accurately measure the filtrate, use potentiometric titration, titrate with silver nitrate titrant to the endpoint, and calculate the content of amantadine hydrochloride in compound acetaminophen and amantadine capsules. (2) Take the contents of the compound acetaminophen and amantadine capsules, grind them into a fine powder, weigh them accurately, place them in a container, add hydrochloric acid and first water, heat to reflux, cool to room temperature, add second water, insert the tip of the burette below the liquid surface, use potentiometric titration, and quickly titrate to the endpoint with sodium nitrite titrant, and calculate the content of acetaminophen in the compound acetaminophen and amantadine capsules.
2. The method for detecting the content of compound acetaminophen and amantadine capsules according to claim 1, characterized in that, The electrode used in the potentiometric titration in step (1) is a silver electrode.
3. The method for detecting the content of compound acetaminophen and amantadine capsules according to claim 1, characterized in that, Step (1): The concentration of compound acetaminophen and amantadine capsules is 15-20 mg / ml.
4. The method for detecting the content of compound acetaminophen and amantadine capsules according to claim 1, characterized in that, In step (1), the concentration of the silver nitrate titrant is 0.08-0.012 mol / L.
5. The method for detecting the content of compound acetaminophen and amantadine capsules according to claim 1, characterized in that, The electrode used in the potentiometric titration in step (2) is a double platinum electrode.
6. The method for detecting the content of compound acetaminophen and amantadine capsules according to claim 1, characterized in that, Step (2): The mass-to-volume ratio of compound acetaminophen capsules to hydrochloric acid, first water, and second water is 0.49g:(45-55)ml:(45-55)ml:(45-55)ml.
7. The method for detecting the content of compound acetaminophen and amantadine capsules according to claim 1, characterized in that, In step (2), the concentration of the hydrochloric acid is 1-6 mol / L.
8. The method for detecting the content of compound acetaminophen and amantadine capsules according to claim 1, characterized in that, In step (2), the concentration of the sodium nitrite titrant is 1-6 mol / L.
9. The method for detecting the content of compound acetaminophen and amantadine capsules according to claim 1, characterized in that, Step (2), the heating and reflux time is 0.8-1.2h.
10. The method for detecting the content of compound acetaminophen and amantadine capsules according to claim 1, characterized in that, Steps (1) and (2) are as follows: the electrode type is mV and the electrode model is DM141-SC; the stirring speed is 25%-35% of the maximum speed of the stirrer; the titrant addition mode is dynamic addition mode, the minimum titration volume is 0.008mL, the maximum titration volume is 0.4mL, and the potential increment setting is 8-10 mV; the balance control mode is set, the potential change threshold is 0.4-0.6 mV, the potential detection interval is 1s, the minimum waiting time is 3s, and the maximum waiting time is 30s; the endpoint determination adopts the standard evaluation mode, and the first derivative threshold is set to 48-52 mV / mL.
Citation Information
Patent Citations
Quality control method of compound acetaminophen and amantadine hydrochloride capsule
CN108254464A
